5Enseleit F, Luscher TF, Ruschitzka F. Darusentan: a new perspective for treatment of resistant hypertension [J]. Expert Opin InVestig Drugs, 2008;17(8) :1255-63.
7Chalmers J. The 1999 WHO-ISH Guidelines for the Management of Hypertension. Med J Aust, 1999,171:458-459.
8Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation, 1999,100:354-360.
9Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA, 2005,294:466-472.
10Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee Prevention, Detection,Evaluation, and Treatment of High Blood Pressure. Hypertension, 2003,42 : 1206-1252.
6Calhoun DA, Jones D, Textor set al. Rsistant hypertension : diagnosis, evaluation and treatment. A scientific statement from the AmericanHeart Association Professional Education Committee of thecouncil for HighBlood pressurs RdJearch [J] . Hypertension, 2008, 51 (6): 1403- 1419.
7安良.老年顽固性高血压34例临床分析[J]中国神经精神疾病杂志,2003(09):封3.
8刘颖.水针疗法[M]北京:人民卫生出版社,20032-9.
9Hamza M,Khamis H. Renal sympathetic denervation for treatment of resistant hypertension: Egyptian experience [J]. J Interv Cardiol, 2014,27 (4) : 423-427.
10Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the symplicity HTN-2 randomized, controlled trial [J]. Circulation, 2012, 126 (25): 2976- 2982.
